|
Volumn 249, Issue 5, 2002, Pages 609-615
|
A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis
|
Author keywords
Amyotrophic lateral sclerosis; Clinical trial; Riluzole
|
Indexed keywords
PLACEBO;
RILUZOLE;
ABDOMINAL PAIN;
ADULT;
AGED;
AMYOTROPHIC LATERAL SCLEROSIS;
APNEA;
ARTICLE;
ASPIRATION PNEUMONIA;
ASTHENIA;
BRONCHITIS;
CARDIOPULMONARY INSUFFICIENCY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEATH;
DIARRHEA;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
DYSPHAGIA;
DYSPNEA;
FEMALE;
HEADACHE;
HEALTH CARE ACCESS;
HUMAN;
HYPERTENSION;
INJURY;
LUNG DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
MUSCLE HYPERTONIA;
NAUSEA;
PAIN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY DISTRESS;
RESPIRATORY FAILURE;
SIDE EFFECT;
SPUTUM ANALYSIS;
SURVIVAL RATE;
SYNCOPE;
TACHYCARDIA;
TREATMENT OUTCOME;
AGE FACTORS;
AGED;
AMYOTROPHIC LATERAL SCLEROSIS;
DISEASE PROGRESSION;
DOUBLE-BLIND METHOD;
DRUG TOLERANCE;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MULTICENTER STUDIES;
NEUROPROTECTIVE AGENTS;
PATIENT SELECTION;
RILUZOLE;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 0036257090
PISSN: 03405354
EISSN: None
Source Type: Journal
DOI: 10.1007/s004150200071 Document Type: Article |
Times cited : (139)
|
References (11)
|